Coronavirus
Coronavirus
-
AstraZeneca, under fire for vaccine safety, releases trial blueprints
Experts are concerned that the company has not been more forthcoming about two participants who became seriously ill after getting its experimental vaccine
-
This 21-year-old launched India's first 'pet sanitiser'
Founder and CEO of Wiggles, Anushka Iyer is on a mission to transform the pet healthcare market in India
-
How COVID has altered the conversation about money
Many women, who have often let their husbands deal with fiscal matters, recognize that they can no longer bury their heads in the sand. In an era when everything feels uncertain, they crave transparency, especially when it comes to money
-
Laid off during Covid-19, these employees turn entrepreneurs
After being laid off, several youngsters are launching their own ventures instead of taking the conventional job-seeking route
-
India's economy: The unknown shape of things to come
With infection numbers still rising, forecasting full year growth just became a lot harder for economists
-
What happened at New York's first pandemic fashion show?
The pandemic has driven most designers to offer videos in lieu of shows. But not Jason Wu. To host a show now is to declare that the runway still matters, even in a pandemic. It better be good
-
No human is limited: Eliud Kipchoge
The running legend from Kenya on why he attempted to be the first human to run a marathon under 2 hours, and how he achieved it
-
From Asia to Africa, China promotes its vaccines to win friends
By some measures, China is leading the global race for a COVID-19 vaccine. It has four candidates in the last phase of clinical trials, more than any other country
-
Can Adar Poonawalla tide over the setback in the Covid-19 vaccine race?
As a volunteer developed an unexplained illness, AstraZeneca, whose coronavirus vaccine Poonawalla's Serum Institute is manufacturing in India, announced a pause in clinical trials
-
Why did AstraZeneca pause their Covid-19 vaccine trial?
AstraZeneca, has announced that it has "voluntarily paused" a randomised clinical trial of its vaccine. The announcement comes after volunteers developed an unexplained illness after taking the vaccine